期刊文献+

维生素D受体TaqI基因多态性与儿童肾病综合征骨代谢的相关性 被引量:5

Correlation Between Vitamin D Receptor(VDR) TaqIGene Polymorphism and Bone Metabolism Disorder in Children,s Nephrotic Syndrome
在线阅读 下载PDF
导出
摘要 目的研究维生素D受体TaqI基因多态性与儿童肾病综合征骨代谢标志物相关性,以期能否根据基因多态性预测儿童骨质疏松症风险,指导药物治疗及评估药物治疗的效果.方法研究对象为2015年5月至2016年11月收住昆明医科大学第一附属医院儿科的70例肾病综合征患儿,维生素D受体TaqI基因多态性检测方法为PCR扩增产物酶切后琼脂糖凝胶电泳检测,骨代谢标志物用生化分析.结果降钙素、25(OH)D3、甲状旁腺激素、钙、磷、碱性磷酸酶在维生素D受体TaqI基因3种基因型(TT,Tt,tt)之间的F值分别为:0.574,2.973,1.947,2.566,0.423,0.242,P值均大于0.05;镁在维生素D受体TaqI基因3种基因型(TT,Tt,tt)之间的F值9.278,P<0.001.在TT基因型患儿中,经骨化三醇治疗2周后与治疗前骨代谢标志物对比,降钙素、25(OH)D3、甲状旁腺激素、镁、磷、碱性磷酸酶t值分别为:0.796,0.290,0.295,0.574,0.830,0.933,P值均大于0.05;钙t值为4.301,P<0.001.在Tt基因型患儿中,经骨化三醇治疗2周后与治疗前骨代谢标志物对比,降钙素、25(OH)D3、甲状旁腺激素、钙、镁、磷、碱性磷酸酶t值分别为:0.722,1.298,1.391,1.511,1.671,1.045,0.368,P>0.05.在tt基因型患儿中,经骨化三醇治疗2周后与治疗前骨代谢标志物对比,降钙素、25(OH)D3、甲状旁腺激素、镁、磷、碱性磷酸酶t值分别为:1.168,1.755,1.787,2.344,1.777,1.808,P值均大于0.05;钙t值为2.458,P<0.005.结论在肾病综合征患儿中,维生素D受体TaqI多态性不能评估骨质疏松风险.TT基因型及tt基因型对骨化三醇治疗的反应性更好,经骨化三醇治疗2周后血清钙较治疗前有明显的升高,骨质疏松症的风险明显减低. Objective In this paper,we study the relationship between vitamin D receptor TaqIgene polymorphism and bone metabolism disorder in children,snephrotic syndrome,in order to predict children's risk of osteoporosisaccording to the genetic polymorphisms,guiding drug treatment and evaluating the effect of drug treatment.Methods The object of the study was the 70 cases of children with nephrotic syndrome in pediatrics in the first affiliated hospital of Kunming Medical University from May 2015 to November 2016.Genotypes of the VDR TaqI gene polymorphism were analyzed using the PCR amplification product enzyme and agarose gel electrophoresis,bone metabolic markers with biochemical analysis.Results The F value of calcitonin(CT).25(OH) D3(VIT-D).parathyroid hormone(PTH).Calcium(Ca).phosphorus(P).alkaline phosphatase(ALP) in the three genotypes(TT TT TT) of vitamin D receptor TaqI gene polymorphism were:0.574,2.973,1.947,2.566,0.423,0.242,P〈0.05.The F value of magnesium(Mg) was 9.278,P0.001.In children with TT genotype,after calcitriol treatment2 weeks,the t value of calcitonin.25(OH) D3.parathyroidhormone.magnesium.phosphorus.alkaline phosphatase were:0.796,0.290,0.295,0.574,0.830,0.933,P〈0.05 compared with treatment before.The t value of Ca was 4.301,P0.001.In children with Tt genotype,the t value of calcitonin.25(OH) D3.parathyroid hormone.calcium.magnesium.phosphorus.alkaline phosphatase were:0.722,1.298,1.391,1.511,1.671,1.045,0.368,P〈0.05.In children with tt genotype,the t value of calcitonin.25(OH) D3.parathyroid hormone.magnesium.phosphorus.alkaline phosphatase were:1.168,1.755,1.787,2.344,1.777,1.808,P〈0.05;the t value of Ca was 2.458,the P0.005.Conclusions In children with nephrotic syndrome,vitamin D receptor TaqI gene polymorphism can assess the risk of osteoporosis,tt genotype has lower risk of osteoporosis as compared with Tt genotype and TT genotype.TT genotype and tt genotype have better reactivity of calcitriol therapy.Serum calcium is significantly elevated after 2 weeks' treatment of calcitriol.The risk for osteoporosis is significantly reduced.
作者 崔坤华 李琪
出处 《昆明医科大学学报》 CAS 2017年第11期69-74,共6页 Journal of Kunming Medical University
基金 云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目(AFRP2014)
关键词 维生素D受体Taq I基因多态性 儿童肾病综合征 骨代谢标志物 骨化三醇 Vitamin D receptor TaqI gene polymorphism Nephrotic syndrome in children Bonemetabolic markers Calcitriol
  • 相关文献

参考文献4

二级参考文献46

  • 1王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 2Moe S,Drueke T,Cunningham J,et al.Definition,evalua-tion,and classification of renal osteodystrophy:a positionstatement from kidney disease:improving global outcomes(KDIGO)[J].Kidney Int,2006,69(11):1945-1953.
  • 3London GM,Marchais SJ,Guerin AP,et al.Arteriosclero-sis,vascular calcifications and cardiovascular disease inuremia[J].Curr Opin Nephrol Hypertens,2005,14(6):525-531.
  • 4Salgueira M,del Toro N,Moreno-Alba R,et al.Vascularcalcification in the uremic patient:a cardiovascular risk[J].Kidney Int Suppl,2003,(85):S119-121.
  • 5Orum O,Hansen M,Jensen CH,et al.Procollagen typeⅠN-terminal Propeptide(PⅠNP)as an indicator of typeⅠcollagen metabolism:ELISA development,reference in-terval,and hypovitaminosis D induced hyperparathyroidism[J].Bone,1996,19(2):157-163.
  • 6Herrmann M,Seibel M.The amino and carboxyterminalcross-linked telopeptides of collagen typeⅠ,NTX-ⅠandCTX-Ⅰ:a comparative review[J].Clinical Chimica Acta,2008,393(5):57-75.
  • 7Balint E,Marshall C F,Sprague S M.Role of interleukin-6 inbeta 2-microglobulin-induced bone mineral dissolution[J].Kidney Int,2000,57(4):1599-1607.
  • 8Feber J,Gaboury I,Ni A,et al.Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome[J].Osteoporos Int,2012,23(2): 751-760.
  • 9Vestergaard P,Rejnmark L,Mosekilde L.Fracture risk associated with systemic and topical corticosteroids[J].J Intern Med,2005,257(4): 374-384.
  • 10Adler RA,Hochberg MC.Glucocorticoid-induced osteoporosis in men[J].J Endocrinol Invest.2011,34(6): 481-484.

共引文献22

同被引文献35

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部